Helena C Maltezou1, Anna Papa2, Sarantoula Ventouri3, Charikleia Tseki4, Danai Pervanidou5, Androula Pavli1, Periklis Panagopoulos3,6, Philothei Markatou7, Elpida Gavana2, Efstratios Maltezos3,6. 1. Department for Interventions in Health-Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece. 2. Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece. 3. Department of Infection Control, University Hospital of Alexandroupolis, Alexandroupolis, Greece. 4. Department of Infection Control, General Hospital of Xanthi, Xanthi, Greece. 5. Department for Epidemiological Surveillance and Intervention, Hellenic Center for Disease Control and Prevention, Athens, Greece. 6. Second Department of Internal Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece. 7. Department of Internal Medicine, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Abstract
BACKGROUND: Nosocomial transmission is a major mode of infection of Crimean-Congo haemorrhagic fever (CCHF). In May 2018, a patient with CCHF was hospitalised in Greece. OBJECTIVE: Our aim was to present the management of healthcare workers (HCWs) to the CCHF case. METHODS: Contact tracing, risk assessment and follow-up of exposed HCWs were performed. Testing (RT-PCR and/or serology) was offered to contacts. Post-exposure prophylaxis (PEP) with ribavirin was considered for high-risk exposures. RESULTS: Ninety-one HCWs were exposed to the case. Sixty-six HCWs were grouped as high-risk exposures. Ribavirin PEP was offered to 29 HCWs; seven agreed to receive prophylaxis. Forty-one HCWs were tested for CCHF infection; none was found positive. Gaps in infection control occurred. DISCUSSION: CCHF should be considered in patients with compatible travel history and clinical and laboratory findings. Early clinical suspicion and laboratory confirmation are imperative for the implementation of appropriate infection control measures. Ribavirin should be considered for high-risk exposures. Infection control capacity for highly pathogenic agents should increase.
BACKGROUND: Nosocomial transmission is a major mode of infection of Crimean-Congo haemorrhagic fever (CCHF). In May 2018, a patient with CCHF was hospitalised in Greece. OBJECTIVE: Our aim was to present the management of healthcare workers (HCWs) to the CCHF case. METHODS: Contact tracing, risk assessment and follow-up of exposed HCWs were performed. Testing (RT-PCR and/or serology) was offered to contacts. Post-exposure prophylaxis (PEP) with ribavirin was considered for high-risk exposures. RESULTS: Ninety-one HCWs were exposed to the case. Sixty-six HCWs were grouped as high-risk exposures. Ribavirin PEP was offered to 29 HCWs; seven agreed to receive prophylaxis. Forty-one HCWs were tested for CCHF infection; none was found positive. Gaps in infection control occurred. DISCUSSION: CCHF should be considered in patients with compatible travel history and clinical and laboratory findings. Early clinical suspicion and laboratory confirmation are imperative for the implementation of appropriate infection control measures. Ribavirin should be considered for high-risk exposures. Infection control capacity for highly pathogenic agents should increase.
Authors: H C Maltezou; L Andonova; R Andraghetti; M Bouloy; O Ergonul; F Jongejan; N Kalvatchev; S Nichol; M Niedrig; A Platonov; G Thomson; K Leitmeyer; H Zeller Journal: Euro Surveill Date: 2010-03-11
Authors: S Lumley; B Atkinson; Sd Dowall; Jk Pitman; S Staplehurst; J Busuttil; Aj Simpson; Ej Aarons; C Petridou; M Nijjar; S Glover; Tj Brooks; R Hewson Journal: Euro Surveill Date: 2014-07-31
Authors: Nicholas G Conger; Kristopher M Paolino; Erik C Osborn; Janice M Rusnak; Stephan Günther; Jane Pool; Pierre E Rollin; Patrick F Allan; Jonas Schmidt-Chanasit; Toni Rieger; Mark G Kortepeter Journal: Emerg Infect Dis Date: 2015-01 Impact factor: 6.883
Authors: Roman Wölfel; Janusz T Paweska; Nadine Petersen; Antoinette A Grobbelaar; Patricia A Leman; Roger Hewson; Marie-Claude Georges-Courbot; Anna Papa; Stephan Günther; Christian Drosten Journal: Emerg Infect Dis Date: 2007-07 Impact factor: 6.883
Authors: H Leblebicioglu; M Sunbul; R Guner; H Bodur; C Bulut; F Duygu; N Elaldi; G Cicek Senturk; Z Ozkurt; G Yilmaz; T E Fletcher; N J Beeching Journal: Clin Microbiol Infect Date: 2016-01-20 Impact factor: 8.067
Authors: Juan F Vesga; Madeleine H A Clark; Edris Ayazi; Andrea Apolloni; Toby Leslie; W John Edmunds; Raphaёlle Métras Journal: PLoS Negl Trop Dis Date: 2022-05-23